We are live on ! Find out more
MD icon

Pediatrix Medical

223 hedge funds and large institutions have $1.78B invested in Pediatrix Medical in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 72 increasing their positions, 93 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

2.27% more ownership

Funds ownership: 91.35%93.62% (+2.3%)

10% less funds holding

Funds holding: 247223 (-24)

11% less capital invested

Capital invested by funds: $1.99B → $1.78B (-$210M)

23% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 93

47% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 45

64% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $3.31M

Holders
223
Holders Change
-24
Holders Change %
-9.72%
% of All Funds
4.89%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
24
Increased
72
Reduced
93
Closed
45
Calls
$1.18M
Puts
$3.31M
Net Calls
-$2.13M
Net Calls Change
-$1.75M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$173M -$12.9M -565,431 -7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$170M -$8.55M -375,019 -5%
ACH
3
ArrowMark Colorado Holdings
Colorado
$120M +$39.1M +1,715,636 +48%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$105M +$10.4M +454,203 +11%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$81.1M +$13.3M +581,554 +19%
Lazard Asset Management
6
Lazard Asset Management
New York
$73.5M +$22.6M +992,282 +44%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$68.7M -$38.8M -1,704,368 -36%
PCP
8
P2 Capital Partners
New York
$62.2M
Fidelity Investments
9
Fidelity Investments
Massachusetts
$52.6M +$8.28M +363,264 +19%
Fidelity International
10
Fidelity International
Bermuda
$52.3M -$2.17M -95,180 -4%
State Street
11
State Street
Massachusetts
$51.6M -$5.42M -237,970 -9%
AQR Capital Management
12
AQR Capital Management
Connecticut
$47.6M +$8.42M +369,608 +21%
Morgan Stanley
13
Morgan Stanley
New York
$37M +$35.9M +1,575,027 +2,534%
CB
14
Cooke & Bieler
Pennsylvania
$32.3M +$193K +8,470 +0.6%
Neuberger Berman Group
15
Neuberger Berman Group
New York
$30.5M +$15M +657,015 +95%
Prudential Financial
16
Prudential Financial
New Jersey
$30M -$4.68M -205,478 -13%
LSV Asset Management
17
LSV Asset Management
Illinois
$25.2M +$16.8M +735,895 +194%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$25M -$2.56M -112,268 -9%
ACB
19
Aristotle Capital Boston
Massachusetts
$24.2M +$3.85M +168,975 +19%
Norges Bank
20
Norges Bank
Norway
$23.4M
First Trust Advisors
21
First Trust Advisors
Illinois
$22.1M -$4.14M -181,586 -16%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$21.2M +$118K +5,188 +0.6%
WG
23
Winton Group
United Kingdom
$18.7M +$529K +23,201 +3%
PCM
24
Palisade Capital Management
New Jersey
$18.1M +$1.25M +54,896 +7%
Goldman Sachs
25
Goldman Sachs
New York
$18M -$2.43M -106,774 -12%

MD Hedge Fund Activity: Q3 2019 in Review

223 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2019, worth a combined $1.78B — down 11% from $1.99B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of MD and 24 opened new positions — a net loss of 21 holders — while 93 trimmed existing stakes and 72 added.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $39.1M. The largest seller was Nordea Investment Management, cutting an estimated $45.4M.

  • 223 institutional investors held Pediatrix Medical (MD) as of Q3 2019, down from 247 in Q2 2019.
  • Funds reported $1.78B of Pediatrix Medical stock for Q3 2019, down 11% quarter-over-quarter.
  • 24 funds opened new Pediatrix Medical positions in Q3 2019 and 45 closed out, a net change of -21 holders.
  • The largest Pediatrix Medical buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $39.1M added.
  • The largest Pediatrix Medical seller in Q3 2019 was Nordea Investment Management, an estimated $45.4M sold.

Based on aggregated 13F filings for Q3 2019.